An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature von Huijbers, Elisabeth J.M., van Beijnum, Judy R., Lê, Chung T., Langman, Sofya, Nowak-Sliwinska, Patrycja, Mayo, Kevin H., Griffioen, Arjan W.

Volltext

Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors von Puik, Jisce R., Le, Chung, Kazemier, Geert, Oprea-Lager, Daniela E., Swijnenburg, Rutger-Jan, Giovannetti, Elisa, Griffioen, Arjan W., Huijbers, Elisabeth JM

Volltext

Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer von Femel, Julia, Huijbers, Elisabeth J M, Saupe, Falk, Cedervall, Jessica, Zhang, Lei, Roswall, Pernilla, Larsson, Erik, Olofsson, Helena, Pietras, Kristian, Dimberg, Anna, Hellman, Lars, Olsson, Anna-Karin

Volltext

Vaccines targeting self‐antigens: mechanisms and efficacy‐determining parameters von Saupe, Falk, Huijbers, Elisabeth J. M., Hein, Tobias, Femel, Julia, Cedervall, Jessica, Olsson, Anna‐Karin, Hellman, Lars

Volltext

Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously von Saupe, Falk, Reichel, Matthias, Huijbers, Elisabeth J. M., Femel, Julia, Markgren, Per-Olof, Evalena Andersson, C., Deindl, Sebastian, Helena Danielson, U., Hellman, Lars T., Olsson, Anna-Karin

Volltext

Corrigendum to “An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature” [Vaccine 36(21) 3054–3060] von Huijbers, Elisabeth J.M., van Beijnum, Judy R., Lê, Chung T., Langman, Sophia, Nowak-Sliwinska, Patrycja, Mayo, Kevin H., Griffioen, Arjan W.

Volltext

Vaccination against the extra domain-B of fibronectin as a novel tumor therapy von Huijbers, Elisabeth J.M, Ringvall, Maria, Femel, Julia, Kalamajski, Sebastian, Lukinius, Agneta, Åbrink, Magnus, Hellman, Lars, Olsson, Anna-Karin

Volltext

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development von Huijbers, Elisabeth J.M, Femel, Julia, Andersson, Karl, Björkelund, Hanna, Hellman, Lars, Olsson, Anna-Karin

Volltext

Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines von Ringvall, Maria, Huijbers, Elisabeth J.M, Ahooghalandari, Parvin, Alekseeva, Ludmila, Andronova, Tatyana, Olsson, Anna-Karin, Hellman, Lars

Volltext

Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer von Femel, Julia, Huijbers, Elisabeth JM, Saupe, Falk, Cedervall, Jessica, Zhang, Lei, Roswall, Pernilla, Larsson, Erik, Olofsson, Helena, Pietras, Kristian, Dimberg, Anna, Hellman, Lars, Olsson, Anna-Karin

Volltext bestellen

HAdV-2-suppressed growth of SV40 T antigen-transformed mouse mammary epithelial cell-induced tumours in SCID mice von Wu, Chengjun, Cao, Xiaofang, Yu, Di, Huijbers, Elisabeth J.M, Essand, Magnus, Akusjärvi, Göran, Johansson, Staffan, Svensson, Catharina

Volltext